The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| FONR | -9.88% | -24.86% | -5.55% | -94% |
| S&P | +12.66% | +85.37% | +13.13% | +4,606% |
FONAR Corp. engages in the design, manufacture, sale, and servicing of magnetic resonance imaging scanners. It operates through the Manufacturing and Servicing of Medical Equipment and Management of Diagnostic Imaging Center segments. The Manufacturing and Servicing of Medical Equipment segment promotes its product, Fonar Upright MRI. The Management of Diagnostic Imaging Center segment offers management, administrative, billing and collection services, office space, equipment, repair, maintenance service and clerical, and non-medical personnel to medical providers through its subsidiary, Health Management Corp. of America. The company was founded by Raymond V. Damadian on July 17, 1978 and is headquartered in Melville, NY.
No news articles found for Fonar.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $26.04M | 4.3% |
| Gross Profit | $10.45M | 4.0% |
| Gross Margin | 40.11% | -0.1% |
| Market Cap | $95.02M | -8.8% |
| Market Cap / Employee | $0.18M | 0.0% |
| Employees | 535 | 2.9% |
| Net Income | $2.67M | -33.2% |
| EBITDA | $4.38M | -34.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $54.28M | 0.2% |
| Accounts Receivable | $84.47M | 5.4% |
| Inventory | 2.7 | -2.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $36.02M | -3.6% |
| Short Term Debt | $3.91M | 2.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 3.47% | -1.2% |
| Return On Invested Capital | 5.38% | -0.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$0.14M | -22.5% |
| Operating Free Cash Flow | $1.73M | 2.1% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 13.39 | 11.47 | 12.20 | 13.61 | 16.18% |
| Price to Book | 0.58 | 0.52 | 0.55 | 0.55 | -11.00% |
| Price to Sales | 0.97 | 0.87 | 0.90 | 0.91 | -11.88% |
| Price to Tangible Book Value | 0.60 | 0.55 | 0.57 | 0.57 | -11.00% |
| Price to Free Cash Flow TTM | 11.85 | 10.82 | 12.43 | 12.81 | 30.68% |
| Enterprise Value to EBITDA | 27.74 | 12.96 | 31.03 | 15.62 | 26.36% |
| Free Cash Flow Yield | 8.4% | 9.2% | 8.0% | 7.8% | -23.48% |
| Return on Equity | 4.7% | 5.0% | 4.9% | 4.3% | -25.30% |
| Total Debt | $38.78M | $39.79M | $38.92M | $39.93M | -3.02% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
